Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059800 · ClinicalTrials.gov registry record · Phase 2
Boron Neutron Capture Therapy in Treating Patients With Melanoma
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00059800: Completed Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
NCT00059800 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00059800, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue. PURPOSE: Phase II trial to study the effectiveness of boron neutron capture therapy in treating patients who have melanoma.
Interventions
- RADIATION boron neutron capture therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-05 |
| Est. Completion | 2004-01 |
| Phase | Phase 2 |
What the finished NCT00059800 record still lists
NCT00059800 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which boron neutron capture therapy is the first listed.
NCT00059800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00059800 about?
NCT00059800 is a clinical study titled "Boron Neutron Capture Therapy in Treating Patients With Melanoma". RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue. PURPOSE: Phase II trial to study the effectiveness of boron neutron capture therapy in treating patients who have melanoma.
What is the current status of trial NCT00059800?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-05. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00059800?
The interventions under investigation include: boron neutron capture therapy (RADIATION).
Who is sponsoring clinical trial NCT00059800?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia